Adhera Therapeutics, Inc. (ATRX)

Number of records: 50
SEC FilingInsiderCompanyTrade DateTransactionSharesAvg. PriceTotal% HoldingsReturn
04-Oct-18 6:48 AM
View: 
Trieu Vuong
Director
10% Owner
Adhera Therapeutics, Inc. (ATRX) 01-Oct-18Disposition 500,000$0.50$250,000.00(12%)
4.04M to 3.54M
12-Jun-17 5:00 PM
View: 
Trieu Vuong
Chairman of the Board
Director
10% Owner
Adhera Therapeutics, Inc. (ATRX) 09-Jun-17Market Purchase 10,000$0.39$3,900.00< 1%
42.29M to 42.3M
0%
08-Jun-17 6:30 PM
View: 
Trieu Vuong
Chairman of the Board
Director
10% Owner
Adhera Therapeutics, Inc. (ATRX) 08-Jun-17Purchase 20,000$0.39$7,800.00< 1%
42.27M to 42.29M
08-Jun-17 6:30 PM
View: 
Trieu Vuong
Chairman of the Board
Director
10% Owner
Adhera Therapeutics, Inc. (ATRX) 07-Jun-17Purchase 2,500$0.38$950.00< 1%
42.26M to 42.27M
07-Apr-17 12:50 PM
View: 
Ramelli Joseph W.
Chief Executive Officer
Adhera Therapeutics, Inc. (ATRX) 07-Apr-17Market Purchase 22,500$0.43$9,562.505%
418.15K to 440.65K
(6%)
07-Apr-17 12:50 PM
View: 
Ramelli Joseph W.
Chief Executive Officer
Adhera Therapeutics, Inc. (ATRX) 06-Apr-17Market Purchase 13,000$0.34$4,368.003%
405.15K to 418.15K
20%
05-Apr-17 5:41 PM
View: 
Ramelli Joseph W.
Chief Executive Officer
Adhera Therapeutics, Inc. (ATRX) 05-Apr-17Market Purchase 97,550$0.31$30,435.6032%
307.6K to 405.15K
29%
08-Feb-17 5:30 PM
View: 
Trieu Vuong
Chairman of the Board
Director
10% Owner
Adhera Therapeutics, Inc. (ATRX) 06-Feb-17Purchase 862,068$0.29$250,000.002%
39.47M to 40.34M
03-Feb-17 12:46 PM
View: 
Ramelli Joseph W.
Chief Executive Officer
Adhera Therapeutics, Inc. (ATRX) 02-Feb-17Grant 100,000----48%
207.6K to 307.6K
22-Nov-16 4:02 PM
View: 
Trieu Vuong
Chairman of the Board
Director
10% Owner
Adhera Therapeutics, Inc. (ATRX) 15-Nov-16Grant 28,378,900----256%
11.09M to 39.47M
02-Jan-15 10:40 AM
View: 
French J Michael
President and CEO
Director
Adhera Therapeutics, Inc. (ATRX) 30-Dec-14Payment of Exercise 309,055$0.33$101,988.00(27%)
1.13M to 822.28K
18-Apr-14 2:20 PM
View: 
Ramelli Joseph W.
Director
Adhera Therapeutics, Inc. (ATRX) 16-Apr-14Market Purchase 26,300$0.76$19,998.5015%
181.3K to 207.6K
(41%)
10-Feb-14 8:12 PM
View: 
Pryor Cashman Llp
10% Owner
Adhera Therapeutics, Inc. (ATRX) 10-Feb-14Market Sale 15,000$1.02$15,270.00(< 1%)
1.61M to 1.59M
56%
10-Feb-14 8:12 PM
View: 
Pryor Cashman Llp
10% Owner
Adhera Therapeutics, Inc. (ATRX) 07-Feb-14Market Sale 59,000$1.01$59,413.00(4%)
1.67M to 1.61M
55%
10-Feb-14 8:12 PM
View: 
Pryor Cashman Llp
10% Owner
Adhera Therapeutics, Inc. (ATRX) 06-Feb-14Market Sale 34,041$0.95$32,304.90(2%)
1.7M to 1.67M
53%
06-Jan-14 9:37 AM
View: 
Ranker Philip C
Former Interim CFO & Secretary
Director
Adhera Therapeutics, Inc. (ATRX) 01-Jan-14Grant 897,303----358921%
0.25K to 897.55K
06-Jan-14 9:36 AM
View: 
French J Michael
President and CEO
Director
Adhera Therapeutics, Inc. (ATRX) 01-Jan-14Grant 1,131,000----84529%
1.34K to 1.13M
06-Jan-14 9:38 AM
View: 
Loren Stefan
Director
Adhera Therapeutics, Inc. (ATRX) 01-Jan-14Grant 181,303----100%
0 to 181.3K
06-Jan-14 9:38 AM
View: 
Ho Richard Theodore
Executive Vice President - R&D
Adhera Therapeutics, Inc. (ATRX) 01-Jan-14Grant 390,000----100%
0 to 390.0K
06-Jan-14 9:39 AM
View: 
Ramelli Joseph W.
Director
Adhera Therapeutics, Inc. (ATRX) 01-Jan-14Grant 181,303----100%
0 to 181.3K
04-Oct-13 6:02 PM
View: 
Pryor Cashman Llp
10% Owner
Adhera Therapeutics, Inc. (ATRX) 04-Oct-13Market Sale 35,000$0.24$8,333.50(2%)
1.74M to 1.7M
(86%)
04-Oct-13 6:02 PM
View: 
Pryor Cashman Llp
10% Owner
Adhera Therapeutics, Inc. (ATRX) 03-Oct-13Market Sale 65,000$0.25$16,334.50(4%)
1.8M to 1.74M
(76%)
17-Aug-11 4:29 PM
View: 
Parker Peter
Director
Adhera Therapeutics, Inc. (ATRX) 16-Aug-11Disposition (other) 40,200$0.24$9,603.78(32%)
124.21K to 84.01K
80%
29-Aug-11 4:44 PM
View: 
French J Michael
President and CEO
Director
Adhera Therapeutics, Inc. (ATRX) 31-Mar-11Acquisition (other) 5,000$0.60$3,000.00148%
3.38K to 8.38K
29-Aug-11 4:46 PM
View: 
Garcia Peter S
Chief Financial Officer
Adhera Therapeutics, Inc. (ATRX) 31-Mar-11Acquisition (other) 5,000$0.60$3,000.00100%
0 to 5.0K
15-Feb-11 11:47 AM
View: 
Parker Peter
Director
Adhera Therapeutics, Inc. (ATRX) 11-Feb-11Acquisition (other) 116,253----1461%
7.96K to 124.21K
27-Jan-11 4:08 PM
View: 
Novartis Bioventures Ltd
10% Owner
Adhera Therapeutics, Inc. (ATRX) 26-Jan-11Market Sale 74,500$1.17$87,130.30(3%)
2.57M to 2.5M
96%
27-Jan-11 4:08 PM
View: 
Novartis Bioventures Ltd
10% Owner
Adhera Therapeutics, Inc. (ATRX) 25-Jan-11Market Sale 93,005$1.12$104,567.00(3%)
2.66M to 2.57M
96%
25-Jan-11 4:30 PM
View: 
Novartis Bioventures Ltd
10% Owner
Adhera Therapeutics, Inc. (ATRX) 24-Jan-11Market Sale 72,800$1.20$87,221.60(3%)
2.74M to 2.66M
96%
25-Jan-11 4:30 PM
View: 
Novartis Bioventures Ltd
10% Owner
Adhera Therapeutics, Inc. (ATRX) 21-Jan-11Market Sale 69,500$1.25$87,218.40(2%)
2.8M to 2.74M
97%
21-Jan-11 4:42 PM
View: 
Novartis Bioventures Ltd
10% Owner
Adhera Therapeutics, Inc. (ATRX) 20-Jan-11Market Sale 45,700$1.35$61,697.50(2%)
2.86M to 2.81M
97%
21-Jan-11 4:43 PM
View: 
Novartis Bioventures Ltd
10% Owner
Adhera Therapeutics, Inc. (ATRX) 20-Jan-11Market Sale 5,700$1.47$8,364.00(< 1%)
2.81M to 2.8M
97%
21-Jan-11 4:42 PM
View: 
Novartis Bioventures Ltd
10% Owner
Adhera Therapeutics, Inc. (ATRX) 19-Jan-11Market Sale 42,800$1.53$65,419.00(1%)
2.9M to 2.86M
97%
29-Aug-11 4:44 PM
View: 
French J Michael
President and CEO
Director
Adhera Therapeutics, Inc. (ATRX) 30-Sep-09Acquisition (other) 875$4.76$4,165.0035%
2.5K to 3.38K
20-Mar-09 5:41 PM
View: 
Quay Steven C
Director
Adhera Therapeutics, Inc. (ATRX) 20-Mar-09Grant 731,275----168%
435.39K to 1.17M
11-Aug-08 5:16 PM
View: 
French J Michael
CEO
Adhera Therapeutics, Inc. (ATRX) 11-Aug-08Market Purchase 10,000$0.75$7,546.33100%
0 to 10.0K
(99%)
05-Aug-08 5:55 PM
View: 
Costantino Henry R
CSO - Delivery
Adhera Therapeutics, Inc. (ATRX) 02-Aug-08Payment of Exercise 438$1.11$486.18(2%)
24.48K to 24.05K
99%
16-Jul-08 8:18 PM
View: 
Costantino Henry R
CSO - Delivery
Adhera Therapeutics, Inc. (ATRX) 14-Jul-08Market Sale 231$1.01$233.31(< 1%)
24.72K to 24.48K
99%
03-Jul-08 1:49 PM
View: 
Costantino Henry R
CSO - Delivery
Adhera Therapeutics, Inc. (ATRX) 02-Jul-08Market Sale 240$1.17$280.80(< 1%)
24.96K to 24.72K
99%
02-Jul-08 4:56 PM
View: 
Duffy Timothy M
Chief Business Officer
Adhera Therapeutics, Inc. (ATRX) 01-Jul-08Market Sale 200$1.19$238.00(< 1%)
56.59K to 56.4K
99%
03-Jul-08 1:49 PM
View: 
Costantino Henry R
CSO - Delivery
Adhera Therapeutics, Inc. (ATRX) 01-Jul-08Market Sale 81$1.19$96.39(< 1%)
25.04K to 24.96K
99%
14-May-08 6:55 PM
View: 
Cross Alexander D
Director
Adhera Therapeutics, Inc. (ATRX) 14-May-08Grant 10,000$1.26$12,635.0036%
28.0K to 38.0K
(99%)
13-May-08 6:13 PM
View: 
Thaw Bruce R/fa
Director
Adhera Therapeutics, Inc. (ATRX) 13-May-08Market Purchase 50,000$1.17$58,521.4044%
114.04K to 164.04K
(99%)
12-May-08 5:27 PM
View: 
Stanewick Gerald T
Director
Adhera Therapeutics, Inc. (ATRX) 12-May-08Market Purchase 10,000$1.14$11,400.006%
165.41K to 175.41K
(99%)
02-Apr-08 4:51 PM
View: 
Brandt Gordon
President
Adhera Therapeutics, Inc. (ATRX) 01-Apr-08Acquisition (other) 1,201$2.00$2,399.003%
40.5K to 41.7K
24%
02-Apr-08 4:52 PM
View: 
Quay Steven C
Chairman and CEO
Director
Adhera Therapeutics, Inc. (ATRX) 01-Apr-08Acquisition (other) 3,500$2.00$6,991.25< 1%
431.12K to 434.62K
24%
19-Mar-08 4:46 PM
View: 
Stanewick Gerald T
Director
Adhera Therapeutics, Inc. (ATRX) 19-Mar-08Market Purchase 5,000$2.40$11,991.003%
160.41K to 165.41K
(100%)
19-Feb-08 5:29 PM
View: 
York Bruce R
Interim CFO, Secretary
Adhera Therapeutics, Inc. (ATRX) 12-Feb-08Grant 14,400----(29%)
49.63K to 35.23K
19-Feb-08 5:35 PM
View: 
Duffy Timothy M
Chief Business Officer
Adhera Therapeutics, Inc. (ATRX) 12-Feb-08Grant 14,400----(20%)
71.0K to 56.59K
20-Dec-07 4:11 PM
View: 
Brandt Gordon
President
Adhera Therapeutics, Inc. (ATRX) 19-Dec-07Grant 18,000----80%
22.5K to 40.5K